Multi-Omic Analyses Characterize the Ceramide/Sphingomyelin Pathway as a Therapeutic Target in Alzheimer’s Disease is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1RF1AG058942-01
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
National Institutes of Health
Grant: 3RF1AG051550-01S1
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 1RF1AG061872-01
Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brain
National Institutes of Health
Grant: 5R03AG054936-02
Neurogenesis in Adult Brain: Gene Networks and Alzheimer’s Disease
National Institutes of Health
Grant: 5R01AG062514-05
Modulation of Alzheimers disease by Herpes simplex virus infection
National Institutes of Health
Grant: 1RF1AG057452-01
Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG015819-07
Risk Factors, Pathology, and Clinical Expressions of AD
National Institutes of Health
Grant: 5U01AG046139-03
A system approach to targeting innate immunity in AD
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5U01AG061359-02
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 1RF1AG059093-01
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment
National Institutes of Health
Grant: 5R01AG046171-03
Metabolic Networks and Pathways in Alzheimer's Disease
National Institutes of Health
Grant: 1R01LM012535-01
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease
Fields of Study
Sustainable Development Goals